Clinical Trials · NCT00753896
Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 134
- Start date
- Oct 2008
- Locations
- 26 sites, 5 countries
- Primary endpoint
- Percentage of Patients Experiencing Adverse Events